Join us for “Testing Embryos: How Far Should We Go?”, the first webinar in our new series, “Frontiers in the Ethics of Human Reproduction.”

Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large?

Connect with our distinguished panelists for a thought-provoking discussion exploring the science, ethics, and future of reproductive genetic screening, unpacking the promise and the pitfalls of this powerful technology.

Our series kicks off with a panel discussion that includes a renowned bioethicist, a leading fertility expert, and an IVF user, moderated by Hastings’ President Vardit Ravitsky.

Panelists:
• Nat De Luca, MA, MDiv – is an ICU chaplain, a student in the Masters of Bioethics program at Harvard, and the father of two darling ‘designer babies.’ He wants to make bioethics theory accessible to intended parents and bring family stories into academic discussions.

• Avner Hershlag, MD – is a fertility doctor with decades of clinical expertise in the field. He is dual board certified in obstetrics and gynecology as well as reproductive endocrinology and infertility (REI).

• Louise Perkins King, MD, JD – is a national leader in reproductive bioethics. She is the director of reproductive bioethics at the Harvard Medical School Center for Bioethics. She is also an assistant professor of obstetrics gynecology and reproductive medicine, and has a gynecology practice at Mass General Brigham. She is former chair of the ethics committee of the American College of Obstetricians and Gynecologists.

Moderator:
• Vardit Ravitsky, PhD – is President and CEO of The Hastings Center for Bioethics and a researcher in the field of reproductive ethics.